The trajectory of medical cannabis sales in Arkansas continues to set new records, with transactions in the state soaring to $23.2 million in July. This robust performance propels the total sales of medical marijuana in Arkansas for the initial seven months of 2023 to an impressive $164.6 million. Remarkably, this figure surpasses the corresponding period’s sales from the previous year by a substantial margin of $7.3 million, as reported by Fayetteville TV station KNWA.

One notable factor contributing to this surge in sales is the marked increase in the number of medical marijuana cardholders within the state. Since the advent of August 2022, the count of patients has surged from 88,893 to 94,059, in accordance with data provided by the Arkansas health department. This expanding patient base is undoubtedly bolstering the state’s medical cannabis market.

Scott Hardin, the official spokesperson for Arkansas’ Department of Finance and Administration, has expressed optimism regarding the foreseeable sales trajectory. He stated that if the current sales patterns persist over the coming months, the total sales for the entirety of 2023 could potentially exceed an impressive $280 million.

In the realm of specific sales figures, medical marijuana dispensaries in Arkansas have effectively marketed and distributed 29,057 pounds of medical cannabis during the initial six months of 2023. This noteworthy achievement reflects a remarkable 23% increase when juxtaposed with the analogous period in the previous year.

The state’s proactive approach to medical cannabis regulation and the growing acceptance of its therapeutic benefits are likely contributors to the surging sales figures. With an expanding patient base and a positive trajectory in sales, Arkansas is solidifying its position as a significant player in the medical cannabis industry.

Arkansas’ medical cannabis market continues to make substantial strides, as evidenced by the record-breaking sales figures in July and the overall upward trend in transactions throughout 2023. The expanding number of medical marijuana cardholders and the persistent efforts of dispensaries are collectively driving this exceptional performance. The state’s potential to achieve sales exceeding $280 million for the year underscores the robust growth of the medical cannabis sector in Arkansas.

 

Source: Mjbizdaily

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

How California’s Delivery Services Are Redefining the Retail Industry

The retail industry has undergone a significant transformation over the past few years, and one of the biggest drivers of this change has been the rise of e-commerce and delivery services. As consumers increasingly turn to online shopping, companies are finding new ways to deliver goods to customers quickly and efficiently. California has been at the forefront of this trend, with delivery services like YesDelivery redefining the retail industry.

Minnesota Becomes 23rd State to Legalize Adult-Use Marijuana, Including Delta-8 THC

Minnesota recently joined the ranks of states that have legalized adult-use marijuana, making it the 23rd state in the U.S. to do so. Governor Tim Walz signed a groundbreaking legalization bill into law on Tuesday, which not only allows the use of marijuana but also permits the sale of hemp-derived cannabinoids like delta-8 THC. This article explores the significance of Minnesota’s unique approach to legalization, the implementation timeline, and the state’s progressive stance on hemp-derived products.

Missouri Division of Cannabis Regulation Initiates Recall of 62,000 Cannabis Products: An In-Depth Look at the Delta Extraction Case and Industry Lessons

The Missouri Division of Cannabis Regulation (DCR) has recently taken a significant step in the cannabis industry by issuing a recall of more than 62,000 cannabis products manufactured by Delta Extraction, LLC. The reason behind this recall lies in the fact that these products were not being compliantly tracked in the statewide track and trace system known as METRC. This failure to adhere to tracking protocols created a situation where the DCR could not verify the origins of these products – whether they were sourced from marijuana cultivated within Missouri and had undergone the necessary testing procedures.

Newsletter